Literature DB >> 8438567

Intracellular transport and virion incorporation of vpx requires interaction with other virus type-specific components.

J C Kappes1, J S Parkin, J A Conway, J Kim, C G Brouillette, G M Shaw, B H Hahn.   

Abstract

Viral protein X (vpx) is a virion-associated HIV-2/SIV accessory protein that enhances viral infectivity and replication in natural target cells. To investigate whether other viral components affect its biosynthesis, subcellular localization, and virion incorporation, we expressed HIV-2 vpx in a mammalian cell system and examined its transport and packaging requirements using an in trans complementation assay. The complete vpx coding region of HIV-2ST was placed under the control of a high-efficiency promoter system (SR alpha) which contained both an SV40 promoter/enhancer region and R/U5 elements of the HTLV-1 LTR. Following transfection of Cos-1 cells, this construct (pSR alpha-vpx) facilitated high level expression of vpx, as demonstrated by Western blot analysis of transfected cell lysates. Moreover, indirect immunofluorescence analysis revealed an intense vpx staining pattern distributed evenly throughout the cytoplasm of transfected cells. This distribution differed markedly from cells expressing wild-type HIV-2 in which vpx localized to the inner surface of the plasma membrane. To determine whether other HIV components were required for this surface localization, we expressed vpx in the context of replication competent HIV-1 and HIV-2 proviruses. Following cotransfection with a vpx-deficient HIV-2 provirus (pXM7), eukaryotically expressed vpx targeted to the plasma membrane and colocalized with HIV-2 p27 gag in a pattern indistinguishable from wild-type HIV-2. Moreover, progeny virions from cotransfected Cos-1 cells contained wild-type amounts of vpx protein, demonstrating that vpx could be efficiently packaged in trans. Under the same experimental conditions, cotransfection of vpx with wild-type HIV-1 (pHXB2) and with vpr-deficient HIV-1 (pR2) failed to result in detectable cell surface targeting or virion incorporation of vpx despite its high level cellular expression. These results demonstrate that efficient intracellular transport and packaging of vpx require interaction with other type-specific virus components.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438567     DOI: 10.1006/viro.1993.1118

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  37 in total

1.  Simian immunodeficiency virus Vpx is imported into the nucleus via importin alpha-dependent and -independent pathways.

Authors:  Prabhat K Singhal; P Rajendra Kumar; Malireddi R K Subba Rao; Mahesh Kyasani; Sundarasamy Mahalingam
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

2.  Viral determinants of integration site preferences of simian immunodeficiency virus-based vectors.

Authors:  Hella Monse; Stephanie Laufs; Seraphin Kuate; W Jens Zeller; Stefan Fruehauf; Klaus Uberla
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Variation of two primate lineage-specific residues in human SAMHD1 confers resistance to N terminus-targeted SIV Vpx proteins.

Authors:  Wei Wei; Haoran Guo; Qimeng Gao; Richard Markham; Xiao-Fang Yu
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

4.  Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes.

Authors:  André Berger; Carsten Münk; Matthias Schweizer; Klaus Cichutek; Silke Schüle; Egbert Flory
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

5.  HIV-2 viral protein X (Vpx) ubiquitination is dispensable for ubiquitin ligase interaction and effects on macrophage infection.

Authors:  Anna McCulley; Lee Ratner
Journal:  Virology       Date:  2012-03-03       Impact factor: 3.616

6.  Adaptation to the interferon-induced antiviral state by human and simian immunodeficiency viruses.

Authors:  Julia Bitzegeio; Marissa Sampias; Paul D Bieniasz; Theodora Hatziioannou
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

7.  Inhibition of human and simian immunodeficiency virus protease function by targeting Vpx-protease-mutant fusion protein into viral particles.

Authors:  X Wu; H Liu; H Xiao; J A Conway; J C Kappes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

8.  Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells.

Authors:  Caroline Goujon; Vanessa Arfi; Thomas Pertel; Jeremy Luban; Julia Lienard; Dominique Rigal; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

Review 9.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

10.  Contribution of SAM and HD domains to retroviral restriction mediated by human SAMHD1.

Authors:  Tommy E White; Alberto Brandariz-Nuñez; Jose Carlos Valle-Casuso; Sarah Amie; Laura Nguyen; Baek Kim; Jurgen Brojatsch; Felipe Diaz-Griffero
Journal:  Virology       Date:  2012-11-13       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.